Calcification of multipotent prostate tumor endothelium

被引:96
作者
Dudley, Andrew C. [1 ]
Khan, Zia A. [1 ]
Shih, Shou-Ching [4 ,5 ]
Kang, Soo-Young [1 ]
Zwaans, Bernadette M. M. [1 ]
Bischoff, Joyce [1 ]
Klagsbrun, Michael [1 ,2 ,3 ]
机构
[1] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[5] Harvard Univ, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.1016/j.ccr.2008.06.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Solid tumors require new blood vessels for growth and metastasis, yet the biology of tumor-specific endothelial cells is poorly understood. We have isolated tumor endothelial cells from mice that spontaneously develop prostate tumors. Clonal populations of tumor endothelial cells expressed hematopoietic and mesenchymal stem cell markers and differentiated to form cartilage- and bone-like tissues. Chondrogenic differentiation was accompanied by an upregulation of cartilage-specific col2a1 and sox9, whereas osteocalcin and the metastasis marker osteopontin were upregulated during osteogenic differentiation. In human and mouse prostate tumors, ectopic vascular calcification was predominately luminal and colocalized with the endothelial marker CD31. Thus, prostate tumor endothelial cells are atypically multipotent and can undergo a mesenchymal-like transition.
引用
收藏
页码:201 / 211
页数:11
相关论文
共 61 条
[1]   Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer [J].
Allan, Alison L. ;
George, Rosamma ;
Vantyghem, Sharon A. ;
Lee, Mark W. ;
Hodgson, Nicole C. ;
Engel, C. Jay ;
Holliday, Ron L. ;
Girvan, David P. ;
Scott, Leslie A. ;
Postenka, Carl O. ;
Al-Katib, Waleed ;
Stitt, Larry W. ;
Uede, Toshimitsu ;
Chambers, Ann F. ;
Tuck, Alan B. .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (01) :233-246
[2]   Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors [J].
Amin, DN ;
Hida, K ;
Bielenberg, DR ;
Klagsbrun, M .
CANCER RESEARCH, 2006, 66 (04) :2173-2180
[3]   Cellular abnormalities of blood vessels as targets in cancer [J].
Baluk, P ;
Hashizume, H ;
McDonald, DM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :102-111
[4]   The multifaceted circulating endothelial cell in cancer: towards marker and target identification [J].
Bertolini, Francesco ;
Shaked, Yuval ;
Mancuso, Patrizia ;
Kerbel, Robert S. .
NATURE REVIEWS CANCER, 2006, 6 (11) :833-845
[5]   Altered angiogenesis and survival in human tumor-derived endothelial cells [J].
Bussolati, B ;
Deambrosis, I ;
Russo, S ;
Deregibus, MC ;
Camussi, G .
FASEB JOURNAL, 2003, 17 (06) :1159-+
[6]   Isolation of renal progenitor cells from adult human kidney [J].
Bussolati, B ;
Bruno, S ;
Grange, C ;
Buttiglieri, S ;
Deregibus, MC ;
Cantino, D ;
Camussi, G .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :545-555
[7]   Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications [J].
Chung, LWK .
CANCER, 2003, 97 (03) :772-778
[8]   Angiogenesis and pericytes in the initiation of ectopic calcification [J].
Collett, GDM ;
Canfield, AE .
CIRCULATION RESEARCH, 2005, 96 (09) :930-938
[9]  
Davidoff AM, 2001, CLIN CANCER RES, V7, P2870
[10]   Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro [J].
DeRuiter, MC ;
Poelmann, RE ;
VanMunsteren, JC ;
Mironov, V ;
Markwald, RR ;
GittenbergerdeGroot, AC .
CIRCULATION RESEARCH, 1997, 80 (04) :444-451